Home / Import refusals / SCS-4788090-5/11/1

FDA Import Refusal SCS-4788090-5/11/1 — Glaxo Operations UK Limited

Glaxo Operations UK Limited — FEI 3003262904

The FDA refused shipment SCS-4788090-5/11/1 from Glaxo Operations UK Limited (United Kingdom) on July 30, 2024. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 472,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
July 30, 2024
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
472,75

Recent inspections

  • 1267917 (VAI Fri Dec 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1102175 (VAI Fri Sep 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1099616 (VAI Fri Jan 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 935343 (NAI Fri Jul 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 898406 (NAI Fri Sep 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-1830807-6/10002/1 (Tue Dec 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • F23-9339962-1/150002/1 (Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • F23-9339758-3/90002/1 (Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0886372-2/11/1 (Fri Feb 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7866347-0/11/1 (Mon Oct 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources